Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;4(1):63-6.
doi: 10.1093/jpids/pit054. Epub 2013 Sep 24.

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults

Lee E Morris  1 , Roberto Posada  1 , Carole J Hickman  2 , Donald R Latner  2 , Tricia A Singh  3 , Alyssa Rautenberg  3 , Jennifer Jao  4 , William J Bellini  2 , Rhoda Sperling  3
Affiliations

Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults

Lee E Morris et al. J Pediatric Infect Dis Soc. 2015 Mar.

Abstract

Among our cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus, few (17.6%) had measles protective antibodies by plaque reduction neutralization (PRN). Agreement was demonstrated between the commercial enzyme immunoassay and the PRN assay (K = 0.59 [95% confidence interval: 0.23-0.95]). Further studies are needed to understand the determinants of immunity in this population.

Keywords: HIV; adolescents; measles immunity; perinatally acquired HIV infection..

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. Clin Infect Dis. 2010;50:1415–8. - PubMed
    1. Melvin A, Mohan K. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics. 2003;111 e641–4. - PubMed
    1. Sutcliffe C, Moss W. Do children infected with HIV receiving HAART need to be revaccinated? Lancet Infect Dis. 2010;10:630–42. - PubMed
    1. Rainwater-Lovett K, Moss W. Immunologic basis for revaccination of HIV-infected children receiving HAART. Future Virol. 2011;6:59–71. - PMC - PubMed
    1. Scott P, Moss W, Gilani Z, Low N. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011;204 S164–78. - PubMed

Publication types

Substances